Myriad Genetics board member steps down
(AP) — Molecular diagnostics company Myriad Genetics Inc. said Tuesday Dr. Mark Skolnick will step down from its board of directors.
Skolnick will remain with the company as a part-time employee in the capacity of senior scientist emeritus. He has served on the board since 1991.
On June 30, the company completed a spin-off of its former research and drug development businesses, which now make up a separate publicly traded company called Myriad Pharmaceuticals.
Sarra Sounds Off, Season 3, Ep 3: Top football teams in action, fantasy update and plays of the week Gregg Sarra sounds off on the Northport and Half Hollow Hills East matchup, plus Tess Ferguson has an update on the high school fantasy football standings and Jared Vailuzzi has the plays of the week.
Sarra Sounds Off, Season 3, Ep 3: Top football teams in action, fantasy update and plays of the week Gregg Sarra sounds off on the Northport and Half Hollow Hills East matchup, plus Tess Ferguson has an update on the high school fantasy football standings and Jared Vailuzzi has the plays of the week.
